From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “spike encoding” 33

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
2020 npj Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, +18 more

357

citations
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, +18 more

45

citations
Immunogenicity of an Ad26-based SARS-CoV-2 Omicron Vaccine in Naïve Mice and SARS-CoV-2 Spike Pre-immune Hamsters
2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 1 patent

Maarten Swart, Adriaan de Wilde, Sonja P. R. Schmit-Tillemans, Johan W. A. Verspuij, Chenandly Daal, Ying Choi, +15 more

2

citations
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits
2023 Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access

Selina Khan, Sonia Marquez-Martinez, Tim Erkens, Adriaan de Wilde, Lea M. M. Costes, Petra Vinken, +8 more

2

citations
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
2024 Scientific Reports article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents

Lucy Rutten, Maarten Swart, Annemart Koornneef, Pascale Bouchier, Sven Blokland, Ava Sadi, +16 more

16

citations
RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
2021 conference-abstract Medicine SARS-CoV-2 and COVID-19 Research

Mathieu Le Gars, JERALD C. SADOFF, Georgi Shukarev, Dirk Heerwegh, Carla Truyers, Gert C. Scheper, +7 more

0

citations
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines
2023 iScience article Medicine SARS-CoV-2 and COVID-19 Research Open access

Julie Van Coillie, Tamás Pongrácz, Tonći Šuštić, Wenjun Wang, Jan Nouta, Mathieu Le Gars, +52 more

24

citations
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia
2024 Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access

Sonia Marquez-Martinez, Selina Khan, Joan E. M. van der Lubbe, Laura Solforosi, Lea M. M. Costes, Ying Choi, +12 more

1

citations
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
2021 Frontiers in Cell and Developmental Biology article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 63 patents

Pedro Morais, Hironori Adachi, Yi‐Tao Yu

274

citations
Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses
2023 JCI Insight article Medicine SARS-CoV-2 and COVID-19 Research Open access

Jeroen van Bergen, Marcel G M Camps, Iris N. Pardieck, Dominique M. B. Veerkamp, Wing Yan Leung, Anouk A. Leijs, +5 more

13

citations
Analysis of BNT162b2‐ and CVnCoV‐elicited sera and of convalescent sera toward SARS‐CoV‐2 viruses
2021 Allergy article Medicine SARS-CoV-2 and COVID-19 Research Open access

Sascha Hein, Marie‐Luise Herrlein, Ines Mhedhbi, Daniela Bender, Vanessa Haberger, Nuka Ivalu Benz, +10 more

11

citations
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
2021 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 14 patents

JERALD C. SADOFF, Mathieu Le Gars, Georgi Shukarev, Dirk Heerwegh, Carla Truyers, Anne Marit de Groot, +20 more

1,216

citations
Immunogenicity and efficacy of Ad26. COV2 .S: An adenoviral vector–based COVID ‐19 vaccine
2022 Immunological Reviews review Medicine SARS-CoV-2 and COVID-19 Research Open access

Mathieu Le Gars, Jenny Hendriks, JERALD C. SADOFF, Martin F. Ryser, Frank Struyf, Macaya Douoguih, +1 more

27

citations
SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access

Ramon Roozendaal, Laura Solforosi, Daniel J Stieh, Jan Serroyen, Roel Straetemans, Frank Wegmann, +16 more

7

citations
Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection
2026 EBioMedicine article Medicine SARS-CoV-2 and COVID-19 Research Open access

Veronica V. Rezelj, Jeroen T. B. M. Tolboom, Nina Hertoghs, Jan Serroyen, Mathieu Le Gars, Frank Struyf, +3 more

0

citations
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
2023 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access

Laura Solforosi, Lea M. M. Costes, Jeroen T. B. M. Tolboom, Katherine McMahan, Tochi Anioke, David L. Hope, +19 more

17

citations
Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial
2022 medRxiv preprint Medicine SARS-CoV-2 and COVID-19 Research Open access

Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, +18 more

1

citations
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
2023 npj Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access

Maarten Swart, Joan E. M. van der Lubbe, Sonja P. R. Schmit-Tillemans, Ella van Huizen, Johan W. A. Verspuij, Ana Izquierdo Gil, +26 more

5

citations
Deciphering in silico the Role of Mutated NaV1.1 Sodium Channels in Enhancing Trigeminal Nociception in Familial Hemiplegic Migraine Type 3
2021 Frontiers in Cellular Neuroscience article Medicine Migraine and Headache Studies Open access

Alina Suleimanova, Max O. Talanov, Arn M. J. M. van den Maagdenberg, Rashid A. Giniatullin

9

citations
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
2021 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access

Ramon Roozendaal, Laura Solforosi, Daniel J Stieh, Jan Serroyen, Roel Straetemans, Anna Dari, +19 more

30

citations
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution
2021 Virology article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents

Irwin Jungreis, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, +6 more

53

citations
The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in Childhood
2020 Biomedicines article Medicine Epilepsy research and treatment Open access

Jan Henje Döring, Afshin Saffari, Thomas Bast, Knut Brockmann, Laura Ehrhardt, Walid Fazeli, +32 more

41

citations
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant
2021 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access

Frank Struyf

35

citations
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
2024 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access

Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, +54 more

18

citations
Why Blood Group A Individuals Are at Risk Whereas Blood Group O Individuals Might Be Protected from SARS-CoV-2 (COVID-19) Infection: A Hypothesis Regarding How the Virus Invades the Human Body via Abo(H) Blood Group-Determining Carbohydrates
2020 Preprints.org preprint Medicine Blood groups and transfusion Open access

Peter Arend

6

citations